- Aspirin (stroke prevention) Drug
Intervention Desc: Antiplatelet agent; inhibits thromboxane A2
Randomized, double-blind, placebo-controlled trial of 505 patients at 6 centers.
Patients were randomized to receive treatment with acetylsalicylic acid (ASA) 1.5 g or placebo. Patients were examined by the clinical investigators at 1 and 3 months after entry and every 3 months thereafter for 2 years.
|Type||Measure||Time Frame||Safety Issue|
|Primary||Recurrent stroke or death.|
|Secondary||Myocardial infarction and transient ischemic attack.|